Department of Cardiology, Thoraxcenter, Erasmus MC, 's-Gravendijkwal 230, 3015 CE, Rotterdam, the Netherlands.
Neth Heart J. 2013 May;21(5):245-8. doi: 10.1007/s12471-013-0393-z.
Percutaneous transluminal septal myocardial ablation using microsphere embolisation is a new interventional technique to treat patients with hypertrophic obstructive cardiomyopathy.
In two patients, considered at high risk for myectomy, targeted septal perforators were occluded with microsphere embolisation instead of alcohol ablation to reduce left ventricular outflow gradient. In both cases the left ventricular outflow tract gradient was immediately reduced. No adverse events occurred.
This is the first clinical experience with Embozene® Microspheres in the Netherlands as an alternative for alcohol septal ablation. In both cases it resulted in immediate improvement in the haemodynamics, without any adverse events.
经皮腔内间隔心肌消融术联合微球栓塞是一种治疗肥厚型梗阻性心肌病的新介入技术。
在两名被认为具有较高风险的患者中,使用微球栓塞而非酒精消融来闭塞特定的间隔穿孔,以降低左心室流出道梯度。在这两种情况下,左心室流出道梯度立即降低。未发生不良事件。
这是荷兰首次将 Embozene®微球用于酒精间隔消融术的替代方法的临床经验。在这两种情况下,它都立即改善了血流动力学,没有任何不良事件。